-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA GRANTS PRIORITY REVIEW TO BEONE MEDICINES’ BRUKINSA COMBINATION IN FIRST-LINE MANTLE CELL LYMPHOMA

Reuters·11/04/2026 14:13:00

Please log in to view news